{
    "name": "SQ18: EMPAGLIFLOZIN-Diabetes Mellitus, Type 2 COP(D)",
    "natural": "Clinical Outcome Pathway (disease)",
    "notes": "SQ18",
    "machine_question": [
        {
            "nodeSpecType": "Named Node",
            "type": "chemical_substance",
            "label": "EMPAGLIFLOZIN",
            "meta": {
                "identifier": "CHEMBL:CHEMBL2107830"
            }
        },
        {
            "nodeSpecType": "Node Type",
            "type": "gene",
            "label": "gene",
            "meta": {}
        },
        {
            "nodeSpecType": "Node Type",
            "type": "biological_process_or_molecular_activity",
            "label": "biological_process_or_molecular_activity",
            "meta": {}
        },
        {
            "nodeSpecType": "Node Type",
            "type": "cell",
            "label": "cell",
            "meta": {}
        },
        {
            "nodeSpecType": "Node Type",
            "type": "anatomical_entity",
            "label": "anatomical_entity",
            "meta": {}
        },
        {
            "nodeSpecType": "Node Type",
            "type": "phenotypic_feature",
            "label": "phenotypic_feature",
            "meta": {}
        },
        {
            "nodeSpecType": "Named Node",
            "type": "disease",
            "label": "Diabetes Mellitus, Type 2",
            "meta": {
                "identifier": "MONDO:0005148"
            }
        }
    ]
}